{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:23:21Z","timestamp":1785414201112,"version":"3.56.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T00:00:00Z","timestamp":1471046400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00404-016-4169-8","type":"journal-article","created":{"date-parts":[[2016,8,13]],"date-time":"2016-08-13T04:58:09Z","timestamp":1471064289000},"page":"1243-1247","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Mifepristone and misoprostol is safe and effective method in the second-trimester pregnancy termination"],"prefix":"10.1007","volume":"294","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0686-0648","authenticated-orcid":false,"given":"Ritva","family":"Nissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Santala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Immonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Talvensaari-Mattila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,13]]},"reference":[{"key":"4169_CR1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/humrep\/der016","volume":"26","author":"M Mentula","year":"2009","unstructured":"Mentula M, Niinim\u00e4ki M, Suhonen S, Hemminki E, Gissler M, Heikinheimo O (2009) Immediate adverse events after second trimester medical termination of pregnancy: result of a nationwide registry study. Hum Reprod 26:927\u2013932","journal-title":"Hum Reprod"},{"key":"4169_CR2","unstructured":"Heino A, Gissler M, Soimula A. Raskaudenkeskeytykset (2011) Tilastoraportti\/THL 32\/2011 Suomen virallinen tilasto, Terveys. http:\/\/www.thl.fi"},{"key":"4169_CR3","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1093\/humrep\/der218","volume":"26","author":"M Mentula","year":"2011","unstructured":"Mentula M, Suhonen S, Heikinheimo O (2011) One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy randomized trial. Hum Reprod 26:2690\u20132697","journal-title":"Hum Reprod"},{"key":"4169_CR4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1472-6483(10)60522-6","volume":"8","author":"O Heikinheimo","year":"2004","unstructured":"Heikinheimo O, Suhonen S, Haukkamaa M (2004) One- and two-day mifepristone-misoprostol intervals are both effective in medical termination of second-trimester pregnancy. Reprod Biomed Online 8:236\u2013239","journal-title":"Reprod Biomed Online"},{"key":"4169_CR5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00404-015-4001-x","volume":"293","author":"C Kiling","year":"2016","unstructured":"Kiling C, Magez J, Hedderich J, Otte S, Kabeliz D (2016) Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetrics history. Arch Gynecol Obstet 293:1113\u20131123","journal-title":"Arch Gynecol Obstet"},{"key":"4169_CR6","doi-asserted-by":"crossref","unstructured":"Wildschut H, Both MI, Medema S, Thomee E, Wildhagen MF, Kapp N (2011) Medical methods for mid-trimester termination of pregnancy. Cochrane Database Syst Rev (Online) CD005216","DOI":"10.1002\/14651858.CD005216.pub2"},{"key":"4169_CR7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/pd.2236","volume":"29","author":"JE Dickinson","year":"2009","unstructured":"Dickinson JE, Doherty DA (2009) Factors influencing the duration of pregnancy termination with vaginal misoprostol for fetal abnormality. Prenat Diagn 29:520\u2013524","journal-title":"Prenat Diagn"},{"key":"4169_CR8","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/AOG.0b013e31819cae06","volume":"11","author":"M Niinim\u00e4ki","year":"2009","unstructured":"Niinim\u00e4ki M, Pouta A, Bloigu A (2009) Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy. Obstet Gynecol 11:845\u2013852","journal-title":"Obstet Gynecol"},{"key":"4169_CR9","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1046\/j.1471-0528.2002.02156.x","volume":"109","author":"PW Ashok","year":"2002","unstructured":"Ashok PW, Templeton A, Wagaarachchi PT, Flett GM (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG 109:1281\u20131289","journal-title":"BJOG"},{"key":"4169_CR10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/AOG.0b013e318227214e","volume":"118","author":"NT Ngoc","year":"2011","unstructured":"Ngoc NT, Shochet T, Raghavan S, Blum J, Nga NT, Minh NT (2011) Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: a randomized controlled trial. Obstet Gynecol 118:601\u2013608","journal-title":"Obstet Gynecol"},{"key":"4169_CR11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijgo.2004.06.025","volume":"87","author":"M Niinim\u00e4ki","year":"2004","unstructured":"Niinim\u00e4ki M, Martikainen H, Talvensaari-Mattila A (2004) Increased risk for medical abortion failure for multiparous women. Int J Gynecol Obstet 87:174\u2013175","journal-title":"Int J Gynecol Obstet"},{"key":"4169_CR12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.contraception.2003.09.006","volume":"69","author":"PW Ashok","year":"2004","unstructured":"Ashok PW, Templeton A, Wagaarachchi PT, Flett GM (2004) Midtrimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 69:51\u201358","journal-title":"Contraception"},{"key":"4169_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2011.07.013","volume":"15","author":"A Faundes","year":"2011","unstructured":"Faundes A (2011) The combination of mifepristone and misoprostol for the termination of pregnancy. Int J Gynecol Obstet 15:1\u20134","journal-title":"Int J Gynecol Obstet"},{"key":"4169_CR14","first-page":"350","volume":"74","author":"M Hoopman","year":"2014","unstructured":"Hoopman M, Hirneth J, Pauluscke-Fr\u00f6hlich B, Yazdi B, Abele D, Wallwiener K, Kagan KO (2014) Influence of mifepristone in induction time for terminations in the second and third trimester. GeFra Sci 74:350\u2013354","journal-title":"GeFra Sci"},{"key":"4169_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejogrb.2010.10.019","volume":"155","author":"N Wagner","year":"2011","unstructured":"Wagner N, Abele H, Hoopmann M, Grischke EM, Blumenstock G, Wallwiener D, Kagan K (2011) Factors influencing the duration of late first and second-trimester termination of pregnancy with prostaglandin derivatives. Eur J Obst Gyn Reprod Biol 155:75\u201378","journal-title":"Eur J Obst Gyn Reprod Biol"},{"key":"4169_CR16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/pd.2012","volume":"28","author":"TK Lo","year":"2008","unstructured":"Lo TK, Lau W, Lai F (2008) The effect of gestational age on the outcome of second-trimester termination of pregnancies for foetal abnormalities. Prenat Diagn 28:508\u20135011","journal-title":"Prenat Diagn"},{"key":"4169_CR17","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00404-015-3722-1","volume":"292","author":"R Tendler","year":"2015","unstructured":"Tendler R, Bornstein J, Kais M, Masri I, Odeh M (2015) Early versus late misoprostol administration after mifepristone for medical abortion. Arch Gynecol Obstet 292:1051\u20131054","journal-title":"Arch Gynecol Obstet"},{"key":"4169_CR18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5455\/2320-1770.ijrcog20130911","volume":"3","author":"U Patel","year":"2013","unstructured":"Patel U, Chauhan K, Singhi S, Kanani M (2013) Second trimester abortion: mifepristone and misoprostol or misoprostol alone? Int J Reprod Contracept Obstet Gynecol 3:315\u2013319","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"4169_CR19","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00404-015-3763-5","volume":"292","author":"G Prema Priya","year":"2015","unstructured":"Prema Priya G, Veena P, Chaturvedula L, Subitha L (2015) A randomized controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum hemorrhage. Arch Gynecol Obstet 292:1231\u20131237","journal-title":"Arch Gynecol Obstet"},{"key":"4169_CR20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod.106.051987","volume":"75","author":"P Grigsby","year":"2006","unstructured":"Grigsby P, Sooranna S, Adu-Amankwa B (2006) Regional expression of prostaglandin E2 and F2alpha receptors in human myometrium, amnion and choriodecidua with advancing gestation and labor. Biol Reprod 75:297\u2013305","journal-title":"Biol Reprod"},{"key":"4169_CR21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.contraception.2008.03.013","volume":"78","author":"O Heikinheimo","year":"2008","unstructured":"Heikinheimo O, Gissler M, Suhonen S (2008) Age, parity, history of abortion and contraceptive choices affect the risk of repeat abortion. Contraception 78:149\u2013154","journal-title":"Contraception"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4169-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-016-4169-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-016-4169-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:40:42Z","timestamp":1498322442000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-016-4169-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,13]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1007\/s00404-016-4169-8","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,13]]}}}